scholarly journals Maternal mortality in the developing world: why do mothers really die?

2008 ◽  
Vol 1 (1) ◽  
pp. 2-6 ◽  
Author(s):  
Gwyneth Lewis

Every year some eight million women suffer preventable or remediable pregnancy-related complications and over half a million will die unnecessarily. Most of these deaths could be averted at little or no extra cost, even where resources are limited, but in order to take action, and develop and implement changes to maternity services to save mothers and newborns lives, a change in cultural attitudes and political will, as well as improvements in the provision of health and social care, is required. Further, to aid programme planners, more in-depth information than that which may already be available through national statistics on maternal mortality rates or death certificate data is urgently needed. What is required is an in-depth understanding of the clinical, social, cultural or any other underlying factors which lead to mothers' deaths. Such information can be obtained by using any of the five methodologies outlined in the World Health Organizations programme and philosophy for maternal death or disability reviews, ‘Beyond the Numbers’, briefly described here and which are now being introduced in a number of countries around the world.

2022 ◽  
Vol 12 ◽  
Author(s):  
Neerja Chowdhary ◽  
Corrado Barbui ◽  
Kaarin J. Anstey ◽  
Miia Kivipelto ◽  
Mariagnese Barbera ◽  
...  

With population ageing worldwide, dementia poses one of the greatest global challenges for health and social care in the 21st century. In 2019, around 55 million people were affected by dementia, with the majority living in low- and middle-income countries. Dementia leads to increased costs for governments, communities, families and individuals. Dementia is overwhelming for the family and caregivers of the person with dementia, who are the cornerstone of care and support systems throughout the world. To assist countries in addressing the global burden of dementia, the World Health Organisation (WHO) developed the Global Action Plan on the Public Health Response to Dementia 2017–2025. It proposes actions to be taken by governments, civil society, and other global and regional partners across seven action areas, one of which is dementia risk reduction. This paper is based on WHO Guidelines on risk reduction of cognitive decline and dementia and presents recommendations on evidence-based, multisectoral interventions for reducing dementia risks, considerations for their implementation and policy actions. These global evidence-informed recommendations were developed by WHO, following a rigorous guideline development methodology and involved a panel of academicians and clinicians with multidisciplinary expertise and representing geographical diversity. The recommendations are considered under three broad headings: lifestyle and behaviour interventions, interventions for physical health conditions and specific interventions. By supporting health and social care professionals, particularly by improving their capacity to provide gender and culturally appropriate interventions to the general population, the risk of developing dementia can be potentially reduced, or its progression delayed.


2019 ◽  
pp. 147-150
Author(s):  
Navneet Kapur ◽  
Robert Goldney

With the increasing recognition of suicide as a major health and social care issue, many suicide prevention organisations have been established locally, nationally and internationally. This chapter includes a number of links to the most prominent of these, but the list is indicative rather than exhaustive. These include the International Association for Suicide Prevention, the International Academy of Suicide Research, the Samaritans, the World Health Organization, and national suicide prevention organizations from across the world.


Author(s):  
Wendy Nicklin ◽  
Carsten Engel ◽  
Jacqui Stewart

Abstract With the rapid acceleration of changes being experienced throughout the world and in particular within health and health and social care, accreditation programmes must keep pace or go the way of the dinosaur. While accreditation has deep roots in some countries, in the past 30 years, it has spread to a considerably larger range of countries in a mix of mandatory and voluntary systems. Accreditation is a tool to improve the quality of healthcare and social care, and in particular, there is recent recognition of its value in low- and middle-income countries, with promotion by the World Health Organization (WHO). The challenge is that with the rapid pace of change, how does accreditation reframe and reposition itself to ensure relevance in 2030? Accreditation must adapt and be relevant in order to be sustainable. This article outlines the fundamental principles, reviews the global trends’ impact on accreditation and the challenges with the existing model and, through the lens of living in 2030, outlines how accreditation programmes will be structured and applied 10 years from now.


Subject Health system capacities. Significance Across the globe, total COVID-19 cases continue to rise at pace; the World Health Organization (WHO) declared Europe as the pandemic’s epicentre on March 13, and the situation in the United States is set to escalate rapidly. The grave situation in Italy provides an insight into what is facing many other countries around the world. Despite the nation-wide introduction of what have been viewed as ‘extreme’ social distancing measures, Italy’s caseload has continued to rise, with hospitals being compared to war-zones. Impacts Countries with aggressive social distancing policies will reduce the likelihood that their healthcare system will be overwhelmed. Social care, such as elderly and vulnerable being taken to hospital when they are unable to cope at home, will be interrupted. Expenditure on health and social care will continue to snowball in order to meet the extra demands on services.


2018 ◽  
Vol 15 (3) ◽  
pp. 49-51 ◽  
Author(s):  
Nick Bouras ◽  
Silvia Davey ◽  
Tracey Power ◽  
Jonathan Rolfe ◽  
Tom Craig ◽  
...  

Maudsley International was set up to help improve people's mental health and well-being around the world. A variety of programmes have been developed by Maudsley International over the past 10 years, for planning and implementing services; building capacity; and training and evaluation to support organisations and individuals, professionals and managers to train and develop health and social care provisions. Maudsley International's model is based on collaboration, sharing expertise and cultural understanding with international partners.


Author(s):  
Eddy Gilissen ◽  
◽  
Chris Mulligan ◽  
Simon Tottman ◽  
Per Troein ◽  
...  

Healthcare systems across the world are looking at ways of maintaining the continuity of supply of medicines to patients in times of crisis.Whilst this is not a new phenomenon, the additional burden placed on the supply chain during COVID-19 has meant it has come more into the spotlight. The need to use a stockpile can be caused by an interruption to supply, a rapid and unexpected peak in demand, or when both an interruption to supply and a peak in demand occur simultaneously. The objectives of a stockpile will guide the portfolio breadth and depth to be held. Stockpile objectives are broadly driven either by government requirements to protect public health or by organisations seeking toachieve commercial gain. These drivers are not mutually exclusive as in the case of holding safety stock and Public Service Obligation stock. An Emergency Stockpile is Public Health driven and held in order to supply essential medicines during a signifcant or catastrophic event. Emergency stockpiles can be split into three categories — preparation for imminent event, disease specifc response and general contingency stockpiles. Governments and authorities determine which products and volumes should be held in an emergency stockpile which may be guided by the World Health Organizations (WHO) l ist of essential medicines.


Author(s):  
Nurbek Madmarov ◽  
Metin Bayrak

Population is an important factor in development of a country. As a constraint, not only the size of the population is important but also its quality in the development process. Women’s health is considered all over the world and the data about this aspect is published by the World Health Organization annually. Among others maternal mortality rate is one of the major problems affecting women’s health and population. Everyday 830 women die due to the problems related to pregnancy and childbirth in the world. While this number is relatively lower in the developed countries, it is higher in the underdeveloped and developing countries. In addition, the maternal mortality rate in the Caucasus and Central Asia ranks in the worst third in the world. In the Kyrgyz Republic, this rate is 82.083333 per 10000 live births which is the worst in the region. Therefore, it is among one of the countries where the maternal mortality should be reduced in the framework of the Millennium Development Goals. In this study, the determinants of maternal mortality rate are analyzed in the Kyrgyz Republic regions during 2000-2015 by using static panel data methods fixed effects and random effects. The findings show that there are significant decreasing effects of GDP, number of assistant physicians, births by skilled staff, improved sanitation facilities, and gender wage equality, there are significant increasing effects of health expenditures, medical facilities, and poverty among women on the maternal mortality.


2021 ◽  
Vol 3 (4) ◽  
pp. 01-05
Author(s):  
Dan Jiang

The coronavirus disease 2019 (COVID-19) has still been spreading around the world, causing an outbreak of acute infectious pneumonia, even a multiple systematic inflammatory disorders following with varied virus. From World Health Organizations (WHO) weekly report in 16th Aug 2021, more than 2 hundred millions (206 693 357) of infected cases and more than 4 million (4 352 488) of deaths are confirmed in the world [1]. The daily report In UK in 18th Aug 2021, there are more than 6 million of infected cases (6 295 613) and 130 thousands of died cases (130 979) are confirmed, fluctuating figures on daily recently on infected and died cases with Covid-19 are reported although the severe case rates, hospitalized rates and died rate have decreased in UK [2]. Due to such bigger amount of patients’ appearance, some post-syndrome of Covid-19 are unavoidably leaving after they are self-healed or treated in the hospitals or anywhere else, they have not recovered completely, still remain some unwanted symptoms, some of them can be quite serious which are possible to disturb them for the rest of their life. We should do and be able doing some significant helps for them with Chinese herbal medicine (TCM). I will discuss these common occurrences of post- syndromes which I have treated: inferior function of lungs, dysfunction of gastrointestinal system, Psychiatric disorder, Post-virus-Chronic-fatigue syndrome, post inflammation of Sexual organs and how manage these post syndromes of Covid-19 with TCM here. TCM should play more effect for helping post-syndromes of Covid-19 after reopening clinics with full of our treating technologies.


2020 ◽  
Vol 35 (4) ◽  
pp. 212-216
Author(s):  
Lauren McNickle ◽  
Robert P. Olympia

School nurses may deal with students presenting with symptoms associated with infections popularized in the news. Although rare, the implications of missing or misdiagnosing these infections are potentially life-threatening and devastating. We present three students presenting with febrile illnesses associated with neurologic symptoms, a rash, and fatigue, focusing on the initial assessment and management of these students and their associated “hot topic” infection. The authors also discuss two public health organizations, Centers for Disease Control and Prevention (https://www.cdc.gov/) and the World Health Organization (https://www.who.int/), online references for the school nurse to research both emerging and common infectious diseases.


2021 ◽  
Vol 10 (38) ◽  
pp. 3424-3429
Author(s):  
Riya Bhargava ◽  
Anurag Ghiloria ◽  
Poorvi Kapoor ◽  
Sameera Dawar ◽  
Nisha Rani Yadav ◽  
...  

BACKGROUND The world is hit by a global pandemic caused by severe acute respiratory syndrome coronavirus, a new genotype of the virus, which causes coronavirus disease, Covid19. The situation has challenged the entire scientific community nationally as well as internationally to fight back this deadly disease. Since its beginning in November 2019, it has disseminated throughout the human race, regardless of all the measures taken by healthcare sectors, governments, and world health organizations as well. Numerous investigations show that this virus uses air as a passage to commute and spread, the disease most commonly spreads through droplet infections and when comes in contact with the mucous membrane, enters the body. Entire medical staff along with scientists of various nations are working perpetually to develop successful vaccines and drugs to fight back this virus. Amongst various vaccines developing across the world, many of them are in their clinical trials and human trial phases and those which have succeeded in all the trial phases are getting delivered to citizens since December 2020. The present article aims to provide a review of the literature on the type of vaccinations that have been developed so far with their mechanism of action and their basic formulations. KEY WORDS Pandemic, SARS-CoV-2, Vaccine, Coronavirus, Antibody, Immunization, COVID-19


Sign in / Sign up

Export Citation Format

Share Document